Companies House does not verify the accuracy of the information filed

Advanced company search

COVANCE CRS ANALYTICS LIMITED

Company number 02801202

Follow this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Company Results (links open in a new window)
Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
26 Dec 2023	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	View PDF Final Gazette dissolved via voluntary strike-off - link opens in a new window - 1 page (1 page)
10 Oct 2023	GAZ1(A)	First Gazette notice for voluntary strike-off	View PDF First Gazette notice for voluntary strike-off - link opens in a new window - 1 page (1 page)
28 Sep 2023	DS01	Application to strike the company off the register	View PDF Application to strike the company off the register - link opens in a new window - 3 pages (3 pages)
04 Jul 2023	TM01	Termination of appointment of Robert Stewart Pringle as a director on 30 June 2023	View PDF Termination of appointment of Robert Stewart Pringle as a director on 30 June 2023 - link opens in a new window - 1 page (1 page)
04 Jul 2023	AP01	Appointment of Thomas Kremer as a director on 30 June 2023	View PDF Appointment of Thomas Kremer as a director on 30 June 2023 - link opens in a new window - 2 pages (2 pages)
02 Jun 2023	CS01	Confirmation statement made on 20 May 2023 with updates	View PDF Confirmation statement made on 20 May 2023 with updates - link opens in a new window - 4 pages (4 pages)
02 Jun 2023	PSC05	Change of details for Covance Laboratories Limited as a person with significant control on 25 June 2021	View PDF Change of details for Covance Laboratories Limited as a person with significant control on 25 June 2021 - link opens in a new window - 2 pages (2 pages)
06 Sep 2022	AA	Accounts for a dormant company made up to 31 December 2021	View PDF Accounts for a dormant company made up to 31 December 2021 - link opens in a new window - 2 pages (2 pages) Download iXBRL
25 May 2022	CS01	Confirmation statement made on 20 May 2022 with no updates	View PDF Confirmation statement made on 20 May 2022 with no updates - link opens in a new window - 3 pages (3 pages)
19 Apr 2022	AA	Full accounts made up to 31 December 2020	View PDF Full accounts made up to 31 December 2020 - link opens in a new window - 20 pages (20 pages)
12 Apr 2022	TM01	Termination of appointment of Stephen Derek Albert Street as a director on 11 April 2022	View PDF Termination of appointment of Stephen Derek Albert Street as a director on 11 April 2022 - link opens in a new window - 1 page (1 page)
24 Mar 2022	DISS40	Compulsory strike-off action has been discontinued	View PDF Compulsory strike-off action has been discontinued - link opens in a new window - 1 page (1 page)
08 Mar 2022	GAZ1	First Gazette notice for compulsory strike-off	View PDF First Gazette notice for compulsory strike-off - link opens in a new window - 1 page (1 page)
09 Sep 2021	SH19	Statement of capital on 9 September 2021 GBP 1.01	View PDF Statement of capital on 9 September 2021 GBP 1.01 - link opens in a new window - 3 pages (3 pages)
27 May 2021	CS01	Confirmation statement made on 20 May 2021 with updates	View PDF Confirmation statement made on 20 May 2021 with updates - link opens in a new window - 5 pages (5 pages)
16 Feb 2021	PSC02	Notification of Covance Laboratories Limited as a person with significant control on 24 December 2020	View PDF Notification of Covance Laboratories Limited as a person with significant control on 24 December 2020 - link opens in a new window - 2 pages (2 pages)
19 Jan 2021	PSC07	Cessation of Covance Crs Limited as a person with significant control on 24 December 2020	View PDF Cessation of Covance Crs Limited as a person with significant control on 24 December 2020 - link opens in a new window - 3 pages (3 pages)
05 Jan 2021	AA	Full accounts made up to 31 December 2019	View PDF Full accounts made up to 31 December 2019 - link opens in a new window - 18 pages (18 pages)
22 Dec 2020	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 4 pages (4 pages)
22 Dec 2020	CAP-SS	Solvency Statement dated 11/12/20	View PDF Solvency Statement dated 11/12/20 - link opens in a new window - 4 pages (4 pages)
22 Dec 2020	RESOLUTIONS	Resolutions RES13 ‐ Share premium account of the company to be cancelled in its entirety 11/12/2020 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Share premium account of the company to be cancelled in its entirety 11/12/2020 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 2 pages (2 pages)
15 Jun 2020	RP04SH01	Second filing of a statement of capital following an allotment of shares on 30 May 2019 GBP 101	View PDF Second filing of a statement of capital following an allotment of shares on 30 May 2019 GBP 101 - link opens in a new window - 7 pages (7 pages)
20 May 2020	CS01	Confirmation statement made on 20 May 2020 with updates	View PDF Confirmation statement made on 20 May 2020 with updates - link opens in a new window - 4 pages (4 pages)
20 May 2020	PSC07	Cessation of Pathfinder Clinical Development Limited as a person with significant control on 4 June 2019	View PDF Cessation of Pathfinder Clinical Development Limited as a person with significant control on 4 June 2019 - link opens in a new window - 1 page (1 page)
20 May 2020	PSC02	Notification of Covance Crs Limited as a person with significant control on 4 June 2019	View PDF Notification of Covance Crs Limited as a person with significant control on 4 June 2019 - link opens in a new window - 2 pages (2 pages)

Tell us what you think of this service Is there anything wrong with this page?